Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey R Oxnard

Showing results (21-30 of 199) with videos related to

Pageof 20
Sort By:
JAMA Oncology|October 25, 2019
Improving Molecular Oncology by Making Results Available to PatientsGeoffrey R Oxnard, Howard Jack West, Jennifer C King
JAMA Oncology|August 20, 2016
Genomic Analysis of Plasma Cell-Free DNA in Patients With CancerGeoffrey R Oxnard, Cloud P Paweletz, Lynette M Sholl
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|September 21, 2018
Precision Medicine in Non-Small Cell Lung Cancer: Current Standards in Pathology and Biomarker InterpretationNoah A Brown, Dara L Aisner, Geoffrey R Oxnard
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 5, 2020
Blood-Based Disease Assessment in SCLC: A Perpetual Proof of Concept or a Clinically Important Tool?Jacob M Sands, Marina S D Milan, Geoffrey R Oxnard
Cancer Cell|April 14, 2023
Not all TMB assays are the same: Clinical validity of robust algorithmic germline filteringRichard S P Huang, Ryon P Graf, Geoffrey R Oxnard
Lung Cancer (Amsterdam, Netherlands)|March 15, 2006
Modeling of mesothelioma growth demonstrates weaknesses of current response criteriaGeoffrey R Oxnard, Samuel G Armato, Hedy L Kindler
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 15, 2017
Application of Plasma Genotyping Technologies in Non-Small Cell Lung Cancer: A Practical ReviewAdrian G Sacher, Kimberly M Komatsubara, Geoffrey R Oxnard
Cancer|April 23, 2014
Management of acquired resistance to epidermal growth factor receptor kinase inhibitors in patients with advanced non-small cell lung cancerAdrian G Sacher, Pasi A Jänne, Geoffrey R Oxnard
JCO Precision Oncology|February 1, 2022
Does Testing Error Underlie Liquid Biopsy Discordance?Cloud P Paweletz, Christie J Lau, Geoffrey R Oxnard
Oncotarget|February 4, 2020
Circulating tumor DNA analysis in the era of precision oncologyRabih Said, Nicolas Guibert, Geoffrey R Oxnard, et al.
Pageof 20

Showing results (21-30 of 199) with videos related to

Sort By:
Pageof 20
JAMA Oncology|October 25, 2019
Improving Molecular Oncology by Making Results Available to PatientsGeoffrey R Oxnard, Howard Jack West, Jennifer C King
JAMA Oncology|August 20, 2016
Genomic Analysis of Plasma Cell-Free DNA in Patients With CancerGeoffrey R Oxnard, Cloud P Paweletz, Lynette M Sholl
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|September 21, 2018
Precision Medicine in Non-Small Cell Lung Cancer: Current Standards in Pathology and Biomarker InterpretationNoah A Brown, Dara L Aisner, Geoffrey R Oxnard
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 5, 2020
Blood-Based Disease Assessment in SCLC: A Perpetual Proof of Concept or a Clinically Important Tool?Jacob M Sands, Marina S D Milan, Geoffrey R Oxnard
Cancer Cell|April 14, 2023
Not all TMB assays are the same: Clinical validity of robust algorithmic germline filteringRichard S P Huang, Ryon P Graf, Geoffrey R Oxnard
Lung Cancer (Amsterdam, Netherlands)|March 15, 2006
Modeling of mesothelioma growth demonstrates weaknesses of current response criteriaGeoffrey R Oxnard, Samuel G Armato, Hedy L Kindler
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 15, 2017
Application of Plasma Genotyping Technologies in Non-Small Cell Lung Cancer: A Practical ReviewAdrian G Sacher, Kimberly M Komatsubara, Geoffrey R Oxnard
Cancer|April 23, 2014
Management of acquired resistance to epidermal growth factor receptor kinase inhibitors in patients with advanced non-small cell lung cancerAdrian G Sacher, Pasi A Jänne, Geoffrey R Oxnard
JCO Precision Oncology|February 1, 2022
Does Testing Error Underlie Liquid Biopsy Discordance?Cloud P Paweletz, Christie J Lau, Geoffrey R Oxnard
Oncotarget|February 4, 2020
Circulating tumor DNA analysis in the era of precision oncologyRabih Said, Nicolas Guibert, Geoffrey R Oxnard, et al.
Pageof 20